Kyle Michael Wool is President of AIkido Pharma Inc.. Currently has a direct ownership of 2.36 Million shares of AIKI, which is worth approximately $8.95 Million. The most recent transaction as insider was on Dec 07, 2022, when has been sold 5,000 shares (Common Stock) at a price of $3.48 per share, resulting in proceeds of $17,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.36M
46.89% 3M change
62.56% 12M change
Total Value Held $8.95 Million

Kyle Michael Wool Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 07 2022
BUY
Open market or private purchase
$17,400 $3.48 p/Share
5,000 Added 1.95%
250,822 Common Stock
Sep 13 2022
BUY
Open market or private purchase
$149,860 $6.32 p/Share
23,712 Added 14.48%
140,068 Common Stock
Sep 12 2022
BUY
Open market or private purchase
$229,766 $6.33 p/Share
36,298 Added 23.78%
116,356 Common Stock
Aug 26 2022
BUY
Grant, award, or other acquisition
$471,528 $6.0 p/Share
78,588 Added 49.54%
80,058 Common Stock
Jul 30 2021
BUY
Grant, award, or other acquisition
$22,000 $0.88 p/Share
25,000 Added 50.0%
25,000 Common Stock
KMW

Kyle Michael Wool

President
New York, NY

Track Institutional and Insider Activities on AIKI

Follow AIkido Pharma Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AIKI shares.

Notify only if

Insider Trading

Get notified when an A Ikido Pharma Inc. insider buys or sells AIKI shares.

Notify only if

News

Receive news related to AIkido Pharma Inc.

Track Activities on AIKI